In the CLL cohort, tumor-exclusive peptides were identified with a frequency of up to 30% (figure 4b and d), with HLA-A*02:01 representing the allotype for 17 of the 20 most abundant peptides (online supplemental figure 10b). The gene discussed is HLA-A; the disease is neoplasm.